InvestorsHub Logo
Followers 23
Posts 2156
Boards Moderated 0
Alias Born 03/18/2013

Re: Notademoc post# 171890

Saturday, 01/12/2019 12:07:16 PM

Saturday, January 12, 2019 12:07:16 PM

Post# of 423884
Notademoc; no such thing as a stupid question. Following up Cbb great Post, I can only add that Woodcock (FDA), actually had no problem with Amarin marketing Vascepa as a dietary supplement (DS). This was contrary to what Amarin management wanted to do. Which probably prompted the 1st Amendment court decision. Which Amarin summarily won. Hindsight says this was the right decision by Amarin to rightfully market Vascepa as a drug vs a Dietary Supplement.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News